Schedule 13G ownership disclosure

CHEMEX PHARMACEUTICALS INC

Security class unavailable

Event date: 2016-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
2,101,809
Percent of class
5.2400%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001019056-17-000212
Form type
SC 13G/A
Filer
ABEONA THERAPEUTICS INC.
CIK
CIK 318306
Filed
Feb 14, 2017
Reporting period
Dec 31, 2016
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub